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Healthcare costs have been rapidly increasing in the United States and consume a 
significant percentage of the Gross Domestic Product (GDP). A percentage of these costs 
are attributed to increased incidences of healthcare overpayments to providers. This study 
examined the impact of these overpayments by provider type, and the underlying reasons 
which resulted in overpayments from the Medicaid perspective. The theoretical 
framework used in this study was Ostrom’s institutional analysis and development (IAD) 
framework. The study used all available data (N = 682) from New York State Medicaid 
Inspector General final audits of providers for Medicaid overpayments. A chi-square test 
of association with a Phi and Cramer’s V analysis was used to test for significance. 
Results of the study were significant and suggest that there is a relationship between 
provider types and Medicaid overpayment amounts, as well as provider types and error 
reasons cited for overpayments. Findings indicate a 56.2% prevalence of overpayments in 
long-term care facilities and 78.9% of dentists failed to meet meaningful use 
requirements, resulting in the most significant error reason for overpayments. 
Recommendations for future study include nationwide collection and aggregation of data 
for overpayment analysis. The study contributes to positive social change by adding to 
limited body of research regarding overpayments and root causes and allowing providers 
and healthcare administration professionals to identify and implement best practices for 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
The Centers for Medicare and Medicaid Services (CMS, 2019) reported that the 
United States (US) spends approximately 17.7% of its gross domestic product (GDP) on 
healthcare expenditures. Furthermore, the US ranks second in terms of highest healthcare 
spending in the world (World Bank, 2017). Federal government financing represented the 
largest portion of all healthcare spending, with 16% of spending attributed to Medicaid 
alone (CMS, 2018). However, as more states adopt Medicaid expansion under the 
Affordable Care Act (ACA), Medicaid spending per enrollee is projected to increase 
significantly (CMS, 2020). 
Given projected increases in Medicaid spending, state budgets will be burdened as 
40% of state funds must be allocated to financing Medicaid (Medicaid and CHIP 
Payment and Access Commission [MACPAC], n.d.). Additionally, MACPAC noted that 
Medicaid consumes the second highest proportion of all state budgets. Not only do states 
bear the responsibility to finance Medicaid, but each state is charged to investigate and 
combat incidences of Medicaid fraud and improper payments through established 
Medicaid Recovery Audit Contractor (RAC) programs (CMS, 2016).  
Recoveries due to Medicaid RAC audits include improper payments and 
overpayments due to potential fraud and other provider billing errors (CMS, 2016). The 
US Government Accountability Office (GAO, 2018) said Medicaid’s vulnerability to 
overpayments is due to the size of programs. States should target efforts in identifying 
predominant root causes of overpayments and concentrate measures in terms of 
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promoting provider compliance to minimize opportunities which reduce the integrity of 
Medicaid programs and burden the US healthcare system. 
This study will have positive social implications by adding to the limited body of 
knowledge on the root causes of Medicaid overpayments from the state perspective. It 
can allow best practices to be developed so that Medicaid overpayments will be reduced 
and funds available to Medicaid beneficiaries may be employed more effectively. 
Effective employment of Medicaid funds could also contribute to lowering overall costs 
of healthcare within the US. 
This section of the study will frame the problem, outline current gaps in the 
research, and delineate the purpose, research questions hypotheses, and the nature of the 
study. Additional sections include the theoretical framework, a review of current 
literature, search strategies employed in finding relevant literature, and definitions of 
pertinent terms used in the literature review. Lastly, Section 1 will highlight assumptions, 
scope, and delimitations and the overall significance of the study. 
Problem Statement 
The Office of the Inspector General (OIG, 2018) reported that $1.6 billion of 
overpayments identified in Medicaid RAC audits currently remain outstanding. 
Overpayments tend to differ by provider type, and among those provider types, different 
reasons are cited for overpayments. Prevalent reasons for overpayments identified in 
audits are frequently defined using data processing and medical review error codes as 
defined by the CMS. It is imperative that primary reasons for these overpayments are 
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investigated as well as why overpayments citations are issued by provider type to prevent 
erosion of state healthcare financing and availability of funds for Medicaid beneficiaries. 
Gaps in Current Research 
No empirical research exists regarding whether there are relationships between 
providers and Medicaid overpayments. Few researchers have developed frameworks or 
models to improve overpayment identification and detect fraud in healthcare claims. The 
OIG conducted an audit of Medicaid providers to find the number of overpayments by 
type of provider and reasons for overpayment. The New York State Office of the 
Comptroller also conducted an audit of Medicaid claims processing which highlighted 
where overpayments were discovered in terms of types of overpayment and provider. 
However, none of those audits examined relationships or associations between types of 
overpayments and providers.  
Purpose of the Study 
With an anticipated 5.7 % projected increase in Medicaid expenditures (CMS, 
2020) and the impact of rising healthcare costs as evidenced by the 17.7% of the GDP 
consumed by healthcare costs, an investigation of the key contributors to Medicaid 
spending is warranted. CMS (2020) predicts an estimated 724.5 billion dollars in 
Medicaid expenditures for 2022, compounding the economic impact of healthcare costs 
by consuming more of the US GDP. Medicaid overpayments to providers drive increases 
in spending and influence the availability of state funding (Ekin, 2019; Stowell et al., 
2018; Shay, 2016). Therefore, the purpose of this quantitative study is to determine if 
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there is any relationship between provider type, reasons cited for overpayments, and 
Medicaid overpayment amounts in New York State (NYS). 
Research Questions and Hypotheses 
RQ1: Based on NYS OIG overpayment audits, is there a statistically significant 
relationship between provider type and Medicaid overpayment amounts? 
H01: Based on NYS OIG overpayment audits, there is no statistically significant 
association between provider type and Medicaid overpayment amounts. 
Ha1: Based on NYS OIG overpayment audits, there is a statistically significant 
association between provider type and Medicaid overpayment amounts. 
RQ2: Based on NYS OIG overpayment audits, is there a statistically significant 
association between provider type and error reasons cited for overpayment? 
H02: Based on NYS OIG overpayment audits, there is no statistically significant 
association between provider type and error reasons cited for overpayment. 
Ha2: Based on the NYS OIG overpayment audits, there is a statistically 
significant association between provider type and error reasons cited for overpayment. 
Theoretical Foundation for the Study 
The theoretical foundation for this study was Elinor Ostrom’s institutional and 
analysis development (IAD) framework. Faridah et al. (2020) said the IAD framework is 
a health policy analysis framework which involves influencing healthcare policies and 
outcomes on an operational level. The IAD framework consists of what Ostrom describes 
as the action arena, its actors, and their actions (McGinnis, 2016). The action arena 
describes the context of where actors, or those who influence outcomes, interact in their 
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environment to effect change based on their actions (Yang & Ren, 2020). Actions are 
contingent on rules which govern actions within an institution, as well as systemic 
processes and constraints, and are influenced by characteristics of the community they 
serve (Ostrom, 2011). 
 McGinnis (2016) said action arenas are composed of operational, collective, and 
constitutional choices. Operational choices are actions exhibited by those who have the 
authority to do so. Moreover, collective choices represent actions which underscore 
adherence to policies that govern decision making in the action arena. Constitutional 
choices highlight whether actions indicate conformity in terms of policies involving 
collective choices. Given collective, operational, and constitutional choices, one 
assumption of the IAD framework is that actors are aware of the actions which result in 
compliance with policies that govern the context of providing services within their 
institution (McGinnis, 2016). 
  Polski and Ostrom (1999) said an institution is defined by processes which govern 
interactions between one or more people and therefore can be conceptualized by 
providers engaged in delivery of services within respective settings.  In other words, an 
institution is an entity that comprises of rules and policies which dictate how individuals 
such as providers work to deliver their services to the populations that they serve in the 
environment where they provide their services. For example, State Medicaid Agencies 
(SMAs) provide resources for providers to ensure they are educated and compliant in 
terms of billing for services (CMS, 2019). Resources such as Medicaid Integrity Manuals 
include legislation which govern overpayments and may include strategies for providers 
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to minimize the likelihood of overpayments due to errors (CMS, 2018). Moreover, 
Medicaid providers are also provided guidance regarding acts such as fraud (CMS, 2018). 
Given resources from Medicaid to promote provider compliance, providers are 
armed to make appropriate collective, operational, and constitutional choices. However, 
provider actions resulting in overpayments may be indicators of nonconformity in terms 
of the aforementioned choices (Ikono et al., 2019). Thus, the IAD framework was used to 
address provider actions involving billing Medicaid, how these actions influence 
Medicaid overpayments and subsequently the Medicaid population, and how those 
actions influence frequency of and reasons why overpayments may occur. 
Nature of the Study 
The study involved using a quantitative correlational approach. I analyzed final 
audit reports of Medicaid overpayments from the NYS Office OMIG for all providers 
available.  The NYS OMIG provides final audit reports indicating amount of 
overpayment as identified in provider audits. Reports also cite the type of provider and 
provider actions which resulted in overpayment. The independent variable in this study is 
the provider type, and the dependent variables are overpayment amounts and types of 
errors which may influence overpayment amounts. Both dependent variables are 
presumed to be contingent on provider type. Lastly, the nature of this data suggested that 
a quantitative approach was most appropriate for data analysis.  
I used a cross-tabulation with a chi-square analysis to determine whether a 
correlation exists between provider types and NYS Medicaid overpayment amounts. I 
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used a cross-tabulation with a chi-square analysis to analyze whether there were any 
statistical associations between provider type and error reasons cited for overpayment.  
To highlight the problem in this research, I conducted a thorough review of 
existing literature on variables within this study. 
Literature Search Strategy 
To conduct the literature review, I searched and combined the key words 
Medicaid overpayments, Medicaid fraud, Medicaid waste and abuse, Medicaid program 
integrity, Medicaid improper billing, and Medicaid billing. I also used the following 
databases: Google Scholar, ScienceDirect, Business Source Complete, PubMed, Gale 
Academic OneFile Select, Academic Search Complete, CINAHL Plus, and Medline with 
Full Text to explore articles related to the research questions. Articles selected for review 
were peer-reviewed and published between 2017 and 2021. I also used credible 
legislative sources involving governing Medicaid. Since there was little to no empirical 
research on Medicaid overpayments by provider type, the literature review involves 
specific topics and approaches which result in Medicaid overpayments. 
Literature Review 
Medicaid 
Under Title XIX of the Social Security Act of 1965, the Medicaid program was 
developed in response to health needs of individuals with low incomes (Piatak, 2015). 
Eligibility for Medicaid at the program’s inception was limited to children, low-income 
families, the disabled, and the elderly (Burger & Combs, 2020). Moreover, the power to 
implement Medicaid and delineate the scope of services under the program was granted 
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to each state with a mandate to cover a range of basic healthcare services from a variety 
of providers (Piatak, 2015). 
Medicaid is both state and federally funded, with federal funds allocated to match 
state expenditures for Medicaid services (Biener et al., 2018). Due to Medicaid 
expansions under the ACA, individuals who are at or under 138% of the federal poverty 
threshold became eligible for Medicaid (Kobayashi et al., 2019). Medicaid is now 
considered one of the largest sources of healthcare funding for individuals in the US 
(Chernof, 2019).  
Providers who accept Medicaid may receive payments directly through fee-for 
service arrangements or managed care contracts with health maintenance organizations 
(Keast et al., 2016; Zuvekas & Cohen, 2016). Additionally, state Medicaid agencies are 
charged with rate setting and payment thresholds for providers (CMS, 2016).  However, 
with continued expansion to states, technological advancements, and increases in the 
production of goods and services, the Medicaid program demands more allocation of 
healthcare financial resources to sustain the program (CMS, 2019). Consequently, this 
places the program at increased risk for incidences of fraud, waste and abuse (CMS, 
2019; Favre et al., 2020). 
Medicaid Audits 
Medicaid audits are governed under the Deficit Reduction Act (DRA) of 2005 
which was enacted with goals to improve the processes by which Medicaid overpayments 
were identified and recouped (CMS, 2019). Under the DRA, the Medicaid Integrity 
Program (MIP) was developed to address issues which contribute to fraud, waste, and 
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abuse of Medicaid funds (CMS, 2019). The terms fraud, waste, and abuse are used 
collectively to describe any acts that may result in improper payment and lead to targeted 
goals involving reducing overpayments and preserving federal and state funds (Ikono et 
al., 2019). 
Other legislation involving Medicaid overpayments include the ACA of 2010. 
The ACA and recent revisions include provisions for protecting Medicaid funds by 
implementing a 60-day rule mandating that providers return overpayments within 60 days 
of discovering the overpayment (Goldin, 2017; Recca, 2016). 
Several other programs and legislation exist under the Medicaid program to 
combat fraud, waste, and abuse, with the False Claims Act (FCA) law being one of the 
most notable for identifying fraud. The Improper Payment Act (IPA) of 2002 was also 
enacted to provide oversight for improper payments involving federal dollars and under 
this legislation, the Payment Error Measurement Rate (PERM) Medicaid program was 
created. Most recently, the Payment Integrity Information Act (PIIA) was enacted to 
mitigate the prevalence of improper payments. 
Since states have oversight of their own Medicaid programs, each is required to 
conduct its own activities to minimize provider actions leading to overpayments. States 
may collaborate with Medicaid Fraud Control Units (MCFUs) or Unified Program 
Integrity Contractors (UPICs) to investigate and/or audit providers for overpayments 
(Beard, 2017; CMS, 2019; GAO, 2018). However, State Medicaid Offices (SMAs) are 




Audits may be initiated via whistleblowers, irregular billing patterns of providers, 
or extrapolation or other statistical sampling methods (Vega, 2018; Shay, 2016). If an 
overpayment is identified during any audit or investigation, the SMA is required to 
initiate efforts to recoup the overpayment and return the federal share.  
Overpayments 
Under Medicaid, overpayments may occur in a variety of ways with fraud the 
most prevalent, and this presents a significant burden on federal and state funding 
(Stowell et al., 2018). Fraud occurs when a provider knowingly and intentionally 
commits an act that would result in an increased financial benefit (Joudaki et al., 2016). 
In some instances, an unintentional act may turn into fraud (Mata, 2016). If a provider 
fails to report the overpayment in a timely manner, it could be potentially investigated as 
a fraudulent act (Shay, 2016). Incidences of fraud may include upcoding, unbundling, 
drug diversion, overtly billing for services not rendered, and treating patients other than 
the actual persons who are recipients of Medicaid (CMS, 2016). Fraud can be committed 
by any type of provider involved in the provision of healthcare services (Joudaki et al., 
2016). 
Identified overpayments may also contribute to errors occurring in data 
processing and medical reviews (CMS, 2019). The CMS has developed codes to 
represent all data processing and medical review codes respectively. These codes 
encompass all errors identified in audits that providers can make which may result in 
overpayment and/or identification of fraud such as unbundling and medically 
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unnecessary services. Errors include those attributed to provider billing claims for 
ineligible beneficiaries (Blasé & Yelowitx, 2019). 
 The CMS also produces annual Medicaid reports which indicate the number of 
errors identified in samples selected for analysis, totaled overpayments, and projected 
nationwide overpayments for each error category. A 2015 Medicaid audit report 
assessing over 1,000 patient records in over five states indicated that half the records 
analyzed lead to overpayments from accounting and billing errors (CMS, 2015). The 
CMS also identifies sources of overpayments and prevalence of errors by provider, as 
well as reasons for overpayments, but does not address statistical associations between 
provider type and rationale for overpayments. 
Fraud 
 In 2018, 1,109 providers and healthcare agencies were convicted of Medicaid 
fraud (OIG, 2018). Trends over a 5-year period demonstrate that 73% of all 
investigations conducted by MCFUs result in fraud and consequences for providers such 
as exclusion from participating in the program (OIG, 2018). Fraud remains a burgeoning 
issue in terms of public healthcare funding (van Capelleveen et al., 2016).  
Improper Billing Practices 
Upcoding. The CMS (2016) said upcoding is one of the most prevalent forms of 
Medicaid fraud among providers. Upcoding occurs when providers submit claims using a 
code which results in more profitable reimbursement as related to services provided 
(Thornton et al., 2015). A nationwide sampling of claims revealed $6,073.35 in improper 
payments due to procedure coding errors with a projected overall improper payment for 
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this category in the amount of $67.92 million dollars (CMS, 2018). Procedure coding 
errors include any claim submission for a procedure that was not billed appropriately by 
the provider and may be an indicator of an overpayment and upcoding (CMS, 2019; 
Grant-Kels et al., 2016). 
Other Improper Billing Practices 
According to the CMS (2016), providers may bill for unnecessary services or 
services that were not rendered to patients. Knopf (2019) reported that Acadia Healthcare 
Company fraudulently received over $8.5 million dollars by billing Medicaid for tests 
that were not needed or used. The actions of Acadia Health Company resulted in over 
$2.1 being depleted from West Virginia state funds allocated for Medicaid, with the 
remainder representing a decrease in federal funding for Medicaid. Moreover, the CMS 
(2019) projected a $0.37 million-dollar loss in Medicaid funds to due medically 
unnecessary procedure errors committed by providers in 2019. 
Providers also engage in a process called unbundling, which results in 
overpayments and fraud (Woodworth et al., 2018). Unbundling occurs when providers 
bill Medicaid or other insurance for services separately when one payment for the 
procedure should be received (Stowell et al., 2018).  Unbundling is one of the most 
prevalent unnecessary procedures, along with improper coding (Thornton et al., 2015).  
Drug Diversion. Drug diversion also represents one of categories the CMS has 
identified as a contributor to fraud and consequent overpayments. Drug diversion occurs 
when prescriptions are used illegally by those for whom they were intended for, nor for 
prescribed reasons (Keast et al., 2015).  
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Kickbacks. Kickbacks also lead to considerable strain on both state and federal 
Medicaid dollars and are regarded as a type of healthcare fraud (OIG, n.d.). According to 
Favre et al. (2020), the federal anti-kickback statute prevents any providers from 
engaging in actions such as recommending a service or product to a patient from which 
they may benefit financially. The OIG (2020) said Oklahoma City Hospital was fined 
$72.3 million dollars for kickbacks involving patient referrals to healthcare organizations 
in which they derived financial benefits. 
Provider Types 
A provider type may be considered any individual or institution involved in the 
provision of services to Medicaid beneficiaries (CMS, 2020). Services include primary 
care as provided by primary care physicians, emergency and other acute care services 
provided in a hospital, dental services, outpatient services, nursing facilities, and care 
provided in the home. Many providers belong to managed care organizations (MCOs) 
which bear the responsibility of maintaining a pool of varying providers that administer 
services to their enrollees who are covered by Medicaid (Bell et al., 2018). 
According to the CMS (2019), providers must abide by state regulations to 
participate in Medicaid through a screening process. Requirements for entry to participate 
may vary from state to state, as states have the power to set their own requirements for 
participation. Moreover, providers are required to be fingerprinted and have their site 
visited and approved as appropriate for participation by the state. Additionally, existing 
providers participating in the Medicaid program are judged to be low or high-risk 
dependent on issues such as whether any previous overpayment exceeds $1,500. 
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Despite Medicaid expansion, providers have been historically hesitant to 
participate in Medicaid due to low reimbursement rates (Spaulding, 2015). As such, 
providers operate within financial constraints with Medicaid as the primary payer and 
commit acts such as unbundling and upcoding due to increased payer incentives 
(Schonberger et al., 2016). Low reimbursement rates also compromise health outcomes, 
with providers delivering subpar care to Medicaid beneficiaries (Chalmers & Compton, 
2017). Sonchak (2015) said increased reimbursement leads to better outcomes in prenatal 
care. Thus, provider overpayments are a direct consequence of seeking higher 
reimbursement rates (Fang & Gong, 2017; Shay, 2016) 
Definitions 
Audit: Sampling process to identify incidences of overpayments in Medicaid 
billing claim submissions (Goldin, 2017). 
Drug Diversion: The act in which providers illegally prescribe or provide 
medication to an individual it was not intended for (Keast et al., 2015). 
Improper Billing: Billing Medicaid inappropriately for including unnecessary 
services or services not actually rendered (Thornton et al., 2015). 
Improper Payment: Any overpayment or underpayment identified in sampling 
Medicaid billing claims (CMS, 2020). 
Medicaid: Federal and state funded program to provide health insurance for 
individuals with low income and children with state eligibility expansions to individuals 
at under 138% of the federal poverty threshold (Kobayashi et al., 2019).  
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Overpayments: Any payment made to a Medicaid provider in excess that is 
attributed to fraud or other billing errors (Shay, 2016). 
Payment Error Measurement Rate (PERM): Medicaid program designed to 
identify payment errors which lead to overpayments (CMS, 2019). 
Provider Type: Any institution or individual involved in the provision of services 
to Medicaid beneficiaries (CMS, 2020). 
State Medicaid Agency (SMA): State organizations which handle the 
administration of Medicaid programs and are responsible for ensuring provider billing 
compliance (CMS, 2019). 
Unbundling: Deconstructing services to maximize reimbursement for claims that 
are paid under a single payment methodology (Stowell et al., 2018).   
Unified Program Integrity Contractors (UPICs): Individuals charged with 
conducting Medicaid audits and investigations to identify overpayments (CMS, 2019). 
Upcoding: Billing for codes which lead to a higher reimbursement but do not 
reflect services provided (Thornton et al., 2015). 
Assumptions 
A major assumption in this study was that NYS OMIG audit reports were a 
credible source of the data. This assumption was necessary so that the study accurately 
reflects outcomes as observed in data analysis. 
Scope and Delimitations 
This study involves all existing Medicaid audits for provider overpayments in 
NYS from the NYS OMIG. The study only includes final audits where an overpayment 
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was identified. Although the CMS provides aggregates nationwide level data on random 
samples to identify overpayments and prevalence of provider errors, the study does not 
include this data since it does not demonstrate which errors are specific to the type of 
provider. As such, only NYS OMIG Medicaid audits were used since they included data 
involving all variables as they relate to a specific type of provider.  
Significance of the Study and Social Change 
As Medicaid is one the largest providers of healthcare funding in the US 
(Chernof, 2019), overpayments heighten the economic burden of healthcare provision 
and increase the portion of the GDP attributed to the sector (CMS, 2019). Consistent 
strains on Medicaid funding also impact beneficiaries’ access to care, which in turn may 
lead to adverse effects on the health of those in need. While methods are being 
implemented for change, a targeted approach to protecting Medicaid funding may be 
warranted). This study will contribute by addressing resources which may be targeted to 
prevent overpayments. It could potentially result in policies to support best practices in 
Medicaid billing. 
Research Gaps 
Based on the literature review, empirical research on statistical associations in 
terms of overpayments and Medicaid dollars is largely nonexistent. Due to the lack of 
existing research indicating relationships among the variables in this study, my intent was 
to conduct this research which addresses statistical associations between overpayments 
and Medicaid when aiding SMA-concentrated efforts to promote provider compliance 




Section 1 included a literature review related to variables which are pivotal and 
provide a foundation for the study. Legislation pertinent to Medicaid billing, audits, and 
overpayments were also explored. The problem of Medicaid overpayments was 
underscored as it related to the theoretical IAD framework. This study was justified based 
on the magnitude of the identified problem. This section also addressed gaps in the 
research topic and how this study will contribute. Section 2 includes the methodology 




Section 2: Research Design and Data Collection 
Introduction 
The purpose of this quantitative study is to determine if there is any relationship 
between provider type, reasons cited for overpayments, and Medicaid overpayment 
amounts. In this section, I outline the research design selected for the study and rationale 
for its selection. This section also includes details regarding data sampling and analysis 
procedures for variables within the study. Lastly, in this section, I highlight any threats to 
the validity of the study and ethical considerations for acquiring and analyzing data. 
Research Design and Rationale 
For this study, I chose a quantitative cross-sectional research design as it was 
most appropriate for determining if any association exists between study variables. The 
independent variable in this study was the provider type with the dependent variables 
being overpayment amounts and types of errors which influence overpayment amounts. 
Both dependent variables are presumed to be contingent on provider type. The 
quantitative cross-sectional research design was also suitable for this study because data 
were captured at a single point in time. Moreover, a cross-sectional research design is 
also useful for finding associations between variables.  
Cross-sectional studies have been used widely in healthcare administration to 
investigate financial resources and how they are used and/or employed ineffectively. This 
cross-sectional study did not present any financial resources constraints, but considerable 
time was required to accumulate data since it was not available as a data set. Data were 
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downloaded individually with additional time needed to extract information relevant to 
variables being studied.  
Methodology 
Population, Sampling, and Sampling Procedures 
The sample population for this study were providers identified in Medicaid audits 
conducted by the NYS OMIG. The NYS OMIG conducts annual audits to identify 
overpayment amounts by provider type and cites reasons for errors. Sample data is 
readily available on the NYS OMIG website, and each audit was downloaded 
individually. Once audits were downloaded, data were extracted from audits for each 
variable. Using an Excel file, categories were created for each provider type, which 
included types of errors cited for overpayment and overpayment amounts. The sample 
only included providers who administered healthcare services during the period between 
2019 and 2020. Providers were physicians, hospitals, and dentists, and included those 
involved in long-term care, home care, nursing, pharmacy, medical equipment, 
transportation, and multi-type facilities.  
Power Analysis 
I used the G*Power analysis calculator to determine the sample size required for 
the study. Creswell (2018) recommended using previous studies as a reference for 
estimating the size of the correlation; however, since no other research has involved 
variables in this study, I used G*Power’s a priori small effect size for generating an 
adequate sample which supports a more representative account of the study population. 
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The analysis also involved using the common alpha and beta values of 0.05 and .80, 
respectively. 
A separate power analysis was conducted to test each hypothesis within the study. 
To test RQ1 and RQ2, a G*Power a priori cross-tabulation analysis indicated a required 
sample size of 1091 (see Table 1). However, the number of cases in the data set (682) 
was determined to be less than recommended in the G*Power analysis for a small effect 
size.  
Table 1 
G*Power Cross-Tabulation Analysis for RQ1 and RQ2 
Input parameters Output parameters 
Effect Size w 0.10 Noncentrality parameter 𝝀 10.9100000 
𝛼 err prob 0.05 Critical 𝝌2 7.8147279 
Power (1-β err prob) 0.80 Total Sample size 1091 
Df 53 Actual power 0.8002982 
 
Research Questions and Hypotheses 
RQ1: Based on NYS OMIG overpayment audits, is there a statistically significant 
relationship between provider type and Medicaid overpayment amounts? 
H01: Based on NYS OMIG overpayment audits, there is no statistically 
significant association between provider type and Medicaid overpayment amounts. 
Ha1: Based on NYS OMIG overpayment audits, there is a statistically significant 
association between provider type and Medicaid overpayment amounts. 
RQ2: Based on NYS OMIG overpayment audits, is there a statistically significant 
association between provider type and error reasons cited for overpayment? 
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H02: Based on NYS OMIG overpayment audits, there is no statistically 
significant association between provider type and error reasons cited for overpayment. 
Ha2: Based on the NYS OMIG overpayment audits, there is a statistically 
significant association between provider type and error reasons cited for overpayment. 
Operationalization 
In this section, I describe main variables which were operationalized in the study. 
Provider Type  
This refers to the nine different types of providers included in the study that are 
responsible for providing clinical services to patients.  
Overpayment Amounts  
This variable refers to an excess dollar figure identified after auditing provider 
types. 
Reasons Cited for Overpayments  
Any provider error resulting in an overpayment as defined by the CMS or 
identified in Medicaid audits (CMS, 2020).  
Data Analysis Plan 
After obtaining Institutional Review Board (IRB) permission to collect data (IRB 
approval number 11-16-20-0603359), audits were downloaded from the OIG website and 
information was entered into an Excel file. Data were analyzed using Statistical Package 
for the Social Sciences (SPSS), with a cross-tabulation analysis for RQ1 and RQ2. For 
cross-tabulation, I used a chi-square test for significance and also reported effect size 
using Phi and Cramer’s V measures of association.  
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Threats to Validity 
Threats to External Validity 
A threat to validity in this study was availability of secondary data for this study. 
NYS OMIG audit data becomes unavailable as more recent data is added to the website. 
As such, the timing of data collection may have affected my ability to gain a large sample 
size as indicated in G*Power analyses, which could have potentially affected 
generalizability of study results. Availability and quantity of new data may minimize this 
threat to external validity. 
Threats to Internal Validity 
A threat to internal validity was that data for providers may change pending an 
appeal of the final audit. If a provider appeals an audit, and it is identified that the 
overpayment amount was incorrect, or there was a determination made where the 
provider is not liable for the overpayment, then this will affect outcomes of the study as 
overpayment amounts, providers, and reasons cited for overpayment can no longer be 
included in the study. However, the nature of the cross-sectional design can mitigate this 
issue, since data were collected and examined at a single point in time. 
Ethical Procedures 
The names of providers and their identifying information was not disclosed. All 
identifying information was removed and providers were classified according to type of 




This section described the design and methods involving data collection. 
Secondary data from the NYS OMIG audits were collected and filtered in order to 
compile information related to the study. Research questions were analyzed using a 
cross-tabulation and chi-square test for independence with Phi and Cramer’s V measures 




Section 3: Presentation of the Results and Findings 
The purpose of this study was to determine if there was any relationship between 
provider type, reasons cited for overpayments, and Medicaid overpayment amounts in 
NYS. The impetus for this study was the vast growth in the amount of Medicaid 
overpayments that have been identified and consequential implications on Medicaid 
funding and impact on beneficiaries. Elinor Ostrom’s institutional and analysis 
development framework served as the theoretical foundation for the study because of its 
widespread use as a health policy analysis framework based on its ability to influence 
healthcare policies and outcomes on an operational level of health services provision. 
Findings from this study may allow relevant stakeholders and Medicaid agencies to 
identify root causes of Medicaid overpayments and implement ways to allocate Medicaid 
funds more effectively.  
 For the study, I used cross-tabulation and a chi-square test for independence with 
Phi and Cramer’s V measures of association as the main statistical method for data 
analysis. This method enabled comparison of means of categorical variables within the 
study and identification of whether there was any statistical significance.  
To test for statistical significance between providers and overpayment amounts, 
providers were separated by respective categories, which included physicians, dentists, 
long-term care, hospital, multi-type facilities, home care, nursing, and an all-other 
category for any other providers. The dependent variables overpayment amount and error 
reasons cited for overpayments were converted to categorical variables by splitting into 
high and low levels based on the median. To test for statistical significance between 
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providers and reasons cited for overpayments, reasons identified were categorized by 
type into the following groups: missing/improper/insufficient documentation, improper 
billing and coding reimbursement for ineligible services and/or providers, failure to meet 
meaningful use requirements, and ineligible enrollees. 
The study was guided by the following research questions and hypotheses: 
RQ1: Based on NYS OMIG overpayment audits, is there a statistically significant 
relationship between provider type and Medicaid overpayment amounts? 
H01: Based on NYS OMIG overpayment audits, there is no statistically 
significant association between provider type and Medicaid overpayment amounts. 
Ha1: Based on NYS OMIG overpayment audits, there is a statistically significant 
association between provider type and Medicaid overpayment amounts. 
RQ2: Based on NYS OMIG overpayment audits, is there a statistically significant 
association between provider type and error reasons cited for overpayment? 
H02: Based on NYS OMIG overpayment audits, there is no statistically 
significant association between provider type and error reasons cited for overpayment. 
Ha2: Based on NYS OMIG overpayment audits, there is a statistically significant 
association between provider type and error reasons cited for overpayment. 
Data Collection of the Secondary Data Set 
The data collection process for this study involved downloading all available final 
audits from the NYS OMIG for the years 2019 and 2020 at the time of collection. Each 
audit was examined to determine the type of provider that was being audited, reasons 
cited for overpayment, and amount of overpayment identified. Audits in which 
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overpayments were not identified were not used in the study. Data were manually 
extracted from audits and consolidated in Microsoft Excel with unique identifiers to 
protect the identity of providers. There were no discrepancies in terms of use of 
secondary data. 
Results 
Table 2 indicates the frequency distribution for each provider according to their 
overpayment amount percentages. Additionally, Tables 3 to 7 depict frequency 
distributions for variables used in the study according to error reasons cited for 
overpayments. 
Table 2  
Frequency Distribution and Chi-Square Results for Overpayment Amount  
  Low High  
Variables Categories N % N % N % 
Provider Dentist 76 13.9 0 0.0 76 11.1 
 Diagnostic and 
Treatment Center 
29 5.3 5 3.6 34 5.0 
 Home Care 85 15.6 14 10.2 99 14.5 
 Hospital 54 9.9 7 5.1 61 8.9 
 Long Term Care 60 11.0 77 56.2 137 20.1 
 Multi-Type 96 17.6 16 11.7 112 16.4 
 Physician 112 20.6 2 1.5 114 16.7 
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 All Other 33 6.1 16 11.7 49 7.2 
χ2(7) = 167.08, p < .001, 𝞿 = 0.50 
Table 3  
Frequency Distribution and Chi-Square Results for Ineligible Enrollees 
  Low High  
Variables Categories N % N % N % 





31 5.1 3 4.3 34 5.0 
 Home Care 83 13.6 16 22.9 99 14.5 
 Hospital 52 8.5 9 12.9 61 8.9 
 Long Term 
Care 
133 21.7 4 5.7 137 20.1 
 Multi-Type 95 15.5 17 24.3 112 16.4 
 Physician 114 18.6 0 0.0 114 16.7 
 All Other 29 4.7 20 28.6 49 7.2 
χ2(7) = 85.42, p < .001, 𝞿 = 0.35 
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Table 4  
Frequency Distribution and Chi-Square Results for Ineligible Services and/or Providers  
  Low High  
Variables Categories N % N % N % 





33 5.3 1 1.7 34 5.0 
 Home Care 95 15.3 4 6.7 99 14.5 
 Hospital 60 9.6 1 1.7 61 8.9 
 Long Term 
Care 
136 21.9 1 1.7 137 20.1 
 Multi-Type 108 17.4 4 6.7 112 16.4 
 Physician 80 12.9 34 56.7 114 16.7 
 All Other 35 5.6 14 23.3 49 7.2 
χ2(7) = 115.07, p < .001, 𝞿 = 0.41 
Table 5  
Frequency Distribution and Chi-Square Results for Improper Billing and Coding 
  Low High  
Variables Categories N % N % N % 
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5 1.4 29 9.0 34 5.0 
 Home Care 21 5.9 78 24.1 99 14.5 
 Hospital 18 5.0 43 13.3 61 8.9 
 Long Term 
Care 
133 37.2 4 1.2 137 20.1 
 Multi-Type 24 6.7 88 27.2 112 16.4 
 Physician 53 14.8 61 18.8 114 16.7 
 All Other 28 7.8 21 6.5 49 7.2 
χ2(7) = 294.64, p < .001, 𝞿 = 0.66 
Table 6  
Frequency Distribution and Chi-Square Results for Improper or Insufficient 
Documentation  
  Low High  
Variables Categories N % N % N % 
Provider Dentist 35 6.1 41 38.3 76 11.1 
 Diagnostic 
and 





 Home Care 80 13.9 19 17.8 99 14.5 
 Hospital 59 10.3 2 1.9 61 8.9 
 Long Term 
Care 
135 23.5 2 1.9 137 20.1 
 Multi-Type 101 17.6 11 10.3 112 16.4 
 Physician 106 18.4 8 7.5 114 16.7 
 All Other 30 5.2 19 17.8 49 7.2 
χ2(7) = 142.25, p < .001, 𝞿 = 0.46 
Table 7  
Frequency Distribution and Chi-Square Results for Failure to Meet Meaningful Use 
Requirements  
  Low High  
Variables Categories N % N % N % 





34 5.8 0 0.0 34 5.0 
 Home Care 99 16.9 0 0.0 99 14.5 
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 Hospital 61 10.4 0 0.0 61 8.9 
 Long Term 
Care 
137 23.3 0 0.0 137 20.1 
 Multi-Type 112 19.1 0 0.0 112 16.4 
 Physician 94 16.0 20 21.1 114 16.7 
 All Other 49 8.3 0 0.0 49 7.2 
χ2(7) = 536.21, p < .001, 𝞿 = 0.89 
 
RQ1 - Results 
Using the cross-tabulation technique in SPSS, I analyzed the data using the chi-
square test of independence and the Phi and Cramer’s V measures of association to report 
the effect size and determine whether there was any statistical association between 
provider type and Medicaid overpayment amounts. The chi-square analysis determined 
that there was a statistically significant association between provider types and Medicaid 
overpayment amounts, χ2(7) = 167.08, p < .001 with a large effect size, 𝞿 = 0.50. 
Findings also indicate that 56.2% of overpayments stem from Long Term Care Facilities. 
Thus, the null hypothesis that there is no statistically significant association between 
provider type and Medicaid Overpayments amounts was rejected. The hypothesis that 
there is a statistically significant association between provider type and Medicaid 
Overpayments amounts was accepted. 
RQ2 - Results 
Results of the chi-square analysis support Ha2 given the statistically significant 
outcome of the test. For all error reasons there was a statistically significant association 
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by provider type which is depicted in Table 8. Figure 1 depicts the prevalence of error 
reasons cited for overpayments by provider type. Findings indicate that the most common 
error reason resulting in an overpayment was a Failure to Meet Meaningful Use 
Requirements by Dentist providers. Thus, the null hypothesis that there is no statistically 
significant association between provider type and the error reasons cited for overpayment 
was rejected. The hypothesis that there is a statistically significant association between 
provider type and the error reasons cited for overpayment was accepted. 
Table 8  
Chi-Square Test of Independence Results with Report of Effect Size by Reason Cited for 
Overpayment 
Reason Cited for Overpayment Chi-Square Test of Independence 
Result with Effect Size 
Effect Size 
Ineligible Enrollees χ2(7) = 85.42, p < .001, 𝞿 = 0.35 Medium 
Ineligible Services and/or 
Providers  
χ2(7) = 115.07, p < .001, 𝞿 = 
0.41 
Medium 
Improper Billing and Coding  χ2(7) = 294.64, p < .001, 𝞿 = 
0.66 
Large 
Missing, Improper or 
Insufficient Documentation  






Failure to Meet Meaningful 
Use Requirements  




Figure 1  




In this section, I used cross-tabulation and a chi-square analysis to determine 
whether there was a statistically significant association between the variables in the 
study. Phi and Cramer’s V measures of association were used in the analysis and to 
determine the effect size. Results of the analysis indicate a statistically significant 
association between provider type and overpayments, and provider type and the error 
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To support the cross-tabulation, all variables were coded into categorical variables 
with values coded for those which were high and low above the median. A frequency 
distribution analysis determined that error reasons cited for overpayments which were 
high above the median were prevalent among specific provider types. For the ineligible 
enrollees category of reasons cited for overpayments, all-other provider types were found 
to be prevalent in contributing to the error. The all-other category includes laboratory, 
transportation, pharmacy, durable medical equipment, and nursing providers. For the 
ineligible services and/or providers’ error reason, physicians were found to be most 
prevalent. The improper billing and coding error reason was prevalent in multi-type 
facilities. Lastly, the error reasons improper or insufficient documentation and failure to 
meet meaningful use requirements were prevalent in dentists only.  
Results of the study support the null hypotheses that there is a statistically 
significant relationship between provider type and Medicaid overpayment amounts, and 
between provider type and the error reasons cited for overpayments. The application to 
professional practice and implication for social change based on the results of this study 
are discussed in Section 4. 
35 
 
Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
The purpose of this study was to determine if there is any relationship between 
provider type, reasons cited for overpayments, and Medicaid overpayment amounts in 
NYS. Previous research on the topic has been limited and focused specifically on 
overpayment reasons such as fraud. Other research has focused on overpayments relating 
to specific diagnoses and procedures through random and nationwide sampling methods, 
as well as cross-sectional studies to examine provider patterns for fraudulent behavior. 
While other research has identified reasons relating to overpayments, little to no research 
has been conducted to investigate statistical associations between provider type, 
overpayments, and reasons cited for the overpayments. 
For this study, I obtained secondary data from the NYS OMIG for the years 2019 
and 2020. Data were Medicaid audits where an overpayment was identified, and reasons 
cited for the overpayment were evident. I performed a cross tabulation in SPSS using Phi 
and Cramer’s V measures of association to examine relationships between variables. 
Findings indicate significant associations between provider types and overpayment 
amounts as well as reasons for overpayment. 
In this section, I discuss interpretations of these findings and the impact and 
implication on professional and social change. 
Interpretation of the Findings 
Results of the study include evidence that there are significant associations 
between provider types, overpayment amounts, and reasons cited for overpayments. 
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Evidence suggests that the nature of the provider can influence the amount of 
overpayment identified in audits. Additionally, reasons cited for overpayments appear to 
be prevalent among specific providers. There is evidence to suggest that dentists or dental 
providers frequently commit errors involving proper documentation and meeting 
meaningful use requirements defined by the Health Information Technology for 
Economic and Clinical Health (HITECH) Act. Under the HITECH Act, providers are 
required to adopt electronic health record (EHR) systems aimed at improving quality of 
care (Lite et al., 2020). Failure to develop required EHR systems will result in an 
overpayment for noncompliance as identified in Medicaid audits. 
Results of the study also suggest that improper billing and coding is frequent 
among multi-type facilities. Improper billing and coding occur for multiple reasons as 
noted in the literature review and may be accidental or fraud based. Whether accidental 
or not, providers are mandated to report any incidences of overpayment in a timely 
manner to reduce the likelihood that it may be considered fraudulent.  
Additional evidence in the study indicates that physicians are more likely to 
receive overpayments for services where they are ineligible to receive payment, or they 
are ineligible to receive payments for services rendered. For all other providers, evidence 
suggests that services were rendered to enrollees who were not eligible for services 
provided. 
Limitations of the Study 
Limitations for this study include the size of facilities audited for the study. A 
larger facility may result in higher incidences of overpayment based on the volume of 
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services it provides. Moreover, NYS OMIG audits are conducted on random facilities 
throughout the state, which may influence the number of audits available for a given type 
of provider. Also, the study was conducted solely in facilities in NYS; however, the size 
of the state and range of provider types are generally applicable to the US.  
Recommendations 
Recommendations for future studies of this nature include aggregating more data 
on healthcare facilities as opposed to random audits. The state can develop a repository 
which houses identified incidences of overpayment by facility type as opposed to random 
audits. This will allow for a more precise identification and analysis of the root causes of 
overpayments as well as more effective ways to combat them. It is also recommended 
that other states employ similar mechanisms to capture overpayment data and identify 
root causes. Another key recommendation is for Medicaid state agencies to aggregate 
overpayment data which the CMS can use for data analysis and identification of 
overpayments as well as root causes nationwide. 
Application to Professional Practice 
The results of this study and current state of overpayment in the US suggest an 
urgent need for practitioners to analyze their own institutional data and develop best 
practices for reducing overpayments. While Medicaid audits are useful in identifying 
overpayments and reasons thereof, those in professional practices can employ their own 
methods for preventing and rapidly identifying overpayments. Evidence from the study 
strongly suggests that promoting compliance in terms of adhering to CMS requirements 
for billing is warranted. Whether it is through training or a culture of billing and 
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reimbursement vigilance throughout institutions, best practices can and should be 
employed by providers and their staff responsible for Medicaid billing. 
Implications for Positive Change 
With the current economic crisis compounded by the COVID-19 pandemic, there 
is a sense of urgency to reduce the economic burden of healthcare. Rising healthcare 
costs which consume a significant portion of the GDP along with healthcare 
overpayments and overpayment recovery represent substantial costs of healthcare. This 
study and other studies of this nature will help to develop knowledge required to mitigate 
healthcare economic issues.  
This study adds to a slim body of knowledge regarding how providers influence 
overpayments and highlighted the imperative for those in the field to exercise measures 
to combat overpayments. Addressing overpayments will allow federal dollars to be 
apportioned appropriately and minimize the likelihood that beneficiaries of Medicaid will 
experience cutbacks or other constraints on their benefits. Moreover, the preservation of 
federal dollars in healthcare can allow other resources to be funded. 
Conclusion 
In this study, I examined the amount and root causes of Medicaid overpayments 
as they relate to varying provider types. Results of the study indicate that there are 
statistical associations between provider types and overpayment amounts and the reasons 
errors occurred. Evidence of the study warrants further investigation into incidences of 
overpayment to combat and reduce their impact on funding Medicaid programs and 
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ensuring that low-income and other Medicaid beneficiaries can retain their health benefits 
and continue to address their health needs. 
Healthcare providers and administration can work collaboratively to promote 
compliance in terms of billing and reimbursement requirements from CMS and other 
relevant agencies. The results of this study can be used to target problem areas and allow 
providers to conduct their own investigations of root causes of overpayments so that they 
can be addressed within the respective provider institutions. Addressing overpayments 
can lead to millions of dollars being preserved and allocated more efficiently for 
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